Results 91 to 100 of about 19,471 (205)

Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study

Cardiovascular Diabetology, 2011
Background Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear.
Køber Lars, Major-Pedersen Atheline, Rask-Madsen Christian, Christiansen Buris, Raunsø Jakob, Hermann Thomas, Falskov Britt, Torp-Pedersen Christian, Dominguez Helena   +8 more
doaj   +1 more source

Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension

, 2018
Zhen-gang Wei,1–3 Feng-xian Wei,1–3 Zi-wei Shao,1–3 Guo-hong Su,1–3 Xue-ping Qi,3 You-cheng Zhang1–3 1Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; 2Hepato-Biliary-Pancreatic ...
Shao Z, Qi X, Zhang Y, Wei F, Wei Z, Su G   +5 more
core  

Protective effect of carvedilol in cardiomyopathy caused by anthracyclines in patients suffering from breast cancer and lymphoma [PDF]

Objective: Anthracyclines can damage the left ventricle, causing cardiomyopathy. This study evaluated the protective effect of carvedilol in cardiomyopathy caused by anthracyclines in patients suffering from breast cancer and lymphoma.
گلدوست, محمد, صالحی, رضوانه, اصفهانی, علی, غفاری, سجاد, عباس نژاد, محسن, زمانی, بیژن   +5 more
core  

Carvedilol in the treatment of portal hypertension

, 2011
Variceal bleeding is a major event in the natural history of end-stage liver disease with a subsequent high mortality rate. Non-selective β-blockers are currently the drugs of choice for preventing first variceal bleeding. Endoscopic rubber band ligation
Hamdan Al-Ghamdi
core   +1 more source

Carvedilol Protects against Doxorubicin-Induced Mitochondrial Cardiomyopathy [PDF]

, 2002
Several cytopathic mechanisms have been suggested to mediate the dose-limiting cumulative and irreversible cardiomyopathy caused by doxorubicin. Recent evidence indicates that oxidative stress and mitochondrial dysfunction are key factors in the ...
Moreno, A. J. M., Leino, R. L., Santos, D. L., Wallace, K. B., Froberg, M. K.   +4 more
core   +1 more source

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction

, 2008
William H Frishman1, Linda S Henderson2, Mary Ann Lukas21Departments of Medicine and Pharmacology, New York Medical College/Westchester Medical Center, Valhalla, NY, USA; 2Cardiovascular and Metabolic Medicine Development Center, GlaxoSmithKline ...
Linda S Henderson, William H Frishman, Mary Ann Lukas   +2 more
core  

Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis

, 2019
Shan Tian,1,* Ruixue Li,2,* Yingyun Guo,1 Xuemei Jia,1 Weiguo Dong1 1Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China; 2Department of Gastroenterology, Renmin Hospital of Macheng City ...
Dong W, Guo Y, Tian S, Jia X, Li R
core  

Carvedilol induces greater control of β2- than β1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium

, 2014
The β-blockers carvedilol and metoprolol provide important therapeutic strategies for heart failure treatment. Therapy with metoprolol facilitates the control by phosphodiesterase PDE3, but not PDE4, of inotropic effects of catecholamines in human ...
Galindo-Tovar, Alejandro, Ravens, Ursula, Kaumann, Alberto J., Gillette, Katherine, Christ, Torsten, Molenaar, Peter, Berk, Emanuel, Engel, Andreas, Gillette, Katherine T., Kaumann, Alberto   +9 more
core   +1 more source

The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis

, 2015
Sheng Chen,1,* Jin-Jun Wang,2,* Qin-Qin Wang,1 Jun-Wei Hu,1 Shuang Dong,1 Li-Juan Hu,1 Yi-Cheng Jian,1 Xin-Yan Liu,2 Gen-Mei Yang,2 Wu-Jun Xiong1 1Department of Hepatology, Tongji University School of Medicine, Shanghai East Hospital, 2Department of ...
Xiong WJ, Liu XY, Yang GM, Chen S, Wang JJ, Wang QQ, Hu JW, Hu LJ, Jian YC, Dong S   +9 more
core  

Carvedilol in glioma treatment alone and with imatinib in vitro

, 2010
The purpose of the study was to investigate whether carvedilol has an antiproliferative effect alone and whether carvedilol provides an additive, synergistic or antagonistic effect on imatinib mesylate-induced cytotoxicity in both C6 glioma monolayer and
Oktem, Gulperi, Erguven, Mine, Sabanci, Akin, Li, Chiang J., Yazihan, Nuray, Bilir, Ayhan, Aktas, Esin   +6 more
core   +1 more source